BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  GENFIT Scraps Elafibranor in NASH, Sets New Strategic Focus

  France’s GENFIT will discontinue the Phase III RESOLVE-IT study of elafibranor in this indication. Why they are shutting it down? Know all about it here.

  July 23, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Trump Touts U.S. Government’s ‘Historic’ COVID-19 Vaccine Deal with Pfizer and BioNTech

  “Hopefully the approval process will go very quickly, and we think we have a winner here,” Trump told White House reporters on Wednesday.

  July 23, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Incyte’s Jakafi Hits Mark in Phase III Graft-Versus-Host Disease Trial

  Jakafi hit the mark, meeting the trial’s primary endpoint of superior overall response rate (ORR) at Week 24 compared to best available therapy (BAT).

  July 23, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Career Advice

  Top Questions to Ask During an Interview Regarding COVID-19

  Here are some of the top questions you should consider asking during an interview regarding COVID-19.

  July 23, 2020

   · 

  2 min read

   · 

  Porschia Parker-Griffin
• 

  Drug Development

  Research Roundup: Progress on COVID-19 Vaccines and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  July 23, 2020

   · 

  7 min read

   · 

  Mark Terry
• 

  Genetown

  VC Group Longwood Fund Closes $170 Million Fund

  With the closing of its latest fund, Longwood Fund, which was founded in 2010, has about $475 million across five funds.

  July 23, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Biopharma Update on the Novel Coronavirus: July 24

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 24, 2020.

  July 23, 2020

   · 

  4 min read

   · 

  Editorial Staff
• 

  Business

  New Membrane Uses Pressure to Help Solve Bioprocess Waste Problem

  A new membrane filtration method could solve the problem of the excessive bioprocessing wastes that many say is a prime impediment to manufacturing pharmaceuticals in the United States.

  July 23, 2020

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  NIH Pushing Large-Scale, Organized COVID-19 Trials

  Francis Collins, the director of the NIH, told STAT they were “really well-powered, rigorously designed clinical trials.”

  July 23, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Glenmark Pharmaceutical’s Antiviral Drug Favipiravir Hits the Mark in Small, Phase III COVID-19 Study

  An antiviral drug, favipiravir, developed by Glenmark Pharmaceuticals, boosted the time it takes COVID-19 patients with mild to moderate symptoms to improve their health in a Phase III study.

  July 23, 2020

   · 

  2 min read

   · 

  Alex Keown